NE-CHMIMO

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Meodipt (talk | contribs) at 21:34, 18 June 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

NE-CHMIMO
Legal status
Legal status
Identifiers
  • [1-(cyclohexylmethyl)-1H-indol-3-yl](naphthalen-1-yl)methanone
CAS Number
Chemical and physical data
FormulaC26H25NO
Molar mass367.492 g·mol−1
3D model (JSmol)
  • O=C(c1cccc2ccccc12)c3cn(CC4CCCCC4)c5ccccc35
  • InChI=1S/C26H25NO/c28-26(23-15-8-12-20-11-4-5-13-21(20)23)24-18-27(17-19-9-2-1-3-10-19)25-16-7-6-14-22(24)25/h4-8,11-16,18-19H,1-3,9-10,17H2
  • Key:HGJYPIZWMHHQKS-UHFFFAOYSA-N

NE-CHMIMO (CHM-018) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] NE-CHMIMO is the 1-cyclohexylmethyl (instead of 1-pentyl) analogue of the first-generation synthetic cannabinoid JWH-018. The corresponding cyclohexylmethyl derivative of JWH-081 had also been reported several months earlier.[3]

See also

References

  1. ^ Verena Angerer; Philippe Bisel; Bjoern Moosmann; Folker Westphal; Volker Auwärter (June 2016). "Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy". Forensic Science International. doi:10.1016/j.forsciint.2016.05.031. PMID 27297324.
  2. ^ "NE-CHMIMO". New Synthetic Drugs Database.
  3. ^ Karen Blakey; Sue Boyd; Sarah Atkinson; Jenna Wolf; Pim M. Slottje; Katrina Goodchild; Jenny McGowan (December 2015). "Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense". Forensic Science International. doi:10.1016/j.forsciint.2015.12.001.